Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019-Induced Vasodilatory Shock: A Retrospective Matched Cohort Study.

Leisman, Daniel E; Mastroianni, Fiore; Fisler, Grace; Shah, Sareen; Hasan, Zubair; Narasimhan, Mangala; Taylor, Matthew D; Deutschman, Clifford S

Leisman, Daniel E; Mastroianni, Fiore; Fisler, Grace; Shah, Sareen; Hasan, Zubair; Narasimhan, Mangala; Taylor, Matthew D; Deutschman, Clifford S.

Afiliação

Leisman DE; Department of Medicine, Massachusetts General Hospital, Boston, MA.
Mastroianni F; Sepsis Research Laboratory, Feinstein Institute for Medical Research, Manhasset, NY.
Fisler G; Sepsis Research Laboratory, Feinstein Institute for Medical Research, Manhasset, NY.
Shah S; Division of Pulmonary and Critical Care Medicine, Northwell Health, New Hyde Park, NY.
Hasan Z; Zucker School of Medicine at Hofstra-Northwell, Hempstead, NY.
Narasimhan M; Zucker School of Medicine at Hofstra-Northwell, Hempstead, NY.
Taylor MD; Division of Critical Care Medicine, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY.
Deutschman CS; Zucker School of Medicine at Hofstra-Northwell, Hempstead, NY.

Crit Care Explor ; 2(10): e0230, 2020 Oct.

Article em En | MEDLINE | ID: mdl-33063034

Palavras-chave

angiotensin II; coronavirus disease 2019; norepinephrine; severe acute respiratory syndrome coronavirus-2 infection; shock; vasoconstrictor agents

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Crit Care Explor Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Marrocos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google